Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.Don't forget to like the fans after reading it. The new fans click to pay attention to Tiger Brother, and the investment will not get lost in the future.
First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;Second, the market is still on the rise. Although the market sentiment is scattered, the trend is still there.Second, the market is still on the rise. Although the market sentiment is scattered, the trend is still there.
Third, cultivate about 10 internationally competitive listed companies in the field;The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide